Mach7 Technologies (M7T.AX) Stock Price

Mach7 Technologies Price

ASX·CLOSED
0.26
​
Market closed

Revenue has compounded at 20.1% per year over the past 19 years to 27.91 M AUD. Mach7 Technologies's net margin stands at -32.0%, down from -15.4% several years earlier. Analysts set a median price target of 0.80 AUD, implying 206.0% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

Mach7 Technologies stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Mach7 Technologies business model & stock analysis

Mach7 Technologies Ltd. generates revenue through its medical imaging software and services for healthcare institutions. The company offers the Mach7 Enterprise Imaging Solution, which includes Enterprise Data Management, Enterprise Diagnostic Viewing, and Departmental Workflow applications. Enterprise Data Management features a Vendor Neutral Archive (VNA) and data administration tools for fast storage, access, retrieval, and viewing of images across healthcare networks with cloud connectivity. Enterprise Diagnostic Viewing provides consolidated access to patient images and data for healthcare professionals, enabling timely diagnosis and treatment. The company serves global healthcare enterprises across North America, Asia Pacific, and the Middle East regions. Mach7 Technologies Ltd. targets healthcare institutions as its primary customers, including hospitals and medical facilities that require advanced imaging and data management solutions. The core products, Mach7 Enterprise Imaging Solution and its components, are sold to these institutions to streamline workflows and improve patient care. The company's focus on global healthcare enterprises ensures a broad market reach in key regions, supporting its revenue streams through software licensing and service contracts. The principal activity of Mach7 Technologies Ltd. is the development and commercialization of medical imaging and data management software solutions. The firm's offerings are designed to meet the needs of healthcare enterprises by providing integrated tools for image storage, access, and diagnostic viewing. By focusing on the North America, Asia Pacific, and Middle East regions, the company capitalizes on the growing demand for efficient healthcare data management systems, driving sales of its software solutions to healthcare institutions.

Frequently asked questions about Mach7 Technologies

Analysts currently set an average price target of 0.80 AUD for the Mach7 Technologies stock (median: 0.80 AUD), implying +206.0 % versus the latest price. The consensus is based on 7 analyst ratings.

6 analysts currently rate the Mach7 Technologies stock: 5 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Mach7 Technologies share trades at 0.16 EUR (0.26 AUD).

The Mach7 Technologies share (M7T.AX) is listed on 2 stock exchanges, including: ASX (M7T.AX).

The revenue of Mach7 Technologies is 27.91 M AUD. This figure is based on current financial data and reflects the company's business performance.

The profit of Mach7 Technologies is -8.93 M AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Mach7 Technologies is currently -6.84. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Mach7 Technologies stock.

The price-to-sales ratio (P/S) of Mach7 Technologies is currently 2.19. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Mach7 Technologies stock.

The Eulerpool Quality Score for Mach7 Technologies is 2/10.

The ISIN of Mach7 Technologies is AU000000M7T0. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Mach7 Technologies is M7T.AX. The ticker symbol is used to trade Mach7 Technologies shares on the stock exchange.

Fair ValueTerminal
0.21 AUD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
310,101.59 AUD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website mach7t.com
Country
Australia
Currency
AUD
Initial public offering
Nov 30, 2005
ISIN
AU000000M7T0
Cusip
Q5692C107
Market capitalization
61.10 M AUDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2027
-15.09
P/Ee 2028
-21.55
P/Ee 2029
258.19
P/S
P/Se
2.06
EV/EBIT
—
P/B Ratio
1.77
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-25.77 %
Last updated Nov 4, 2026, 7:34 PM

Mach7 Technologies Peer Group

Mach7 Technologies Ticker

ASX · M7T.AXOTC · TDMMF

Mach7 Technologies FIGI

S8M:GR · BBG000BPZWZ4S8M:GB · BBG000BPZZY8M7T:AU · BBG000JMLNT5M7T:AT · BBG000JMLPC8M7T:AH · BBG002F3LPB13DMEUR:EO · BBG0084HFC433DMEUR:XH · BBG0084HFC703DMEUR:XF · BBG0084HFC983DMEUR:XE · BBG0084HFCC43DMEUR:XJ · BBG0084HFCD33DMEUR:XL · BBG0084HFCF13DMEUR:XG · BBG0084HFCG0